Accelerate Cambridge Ventures Hall of Fame

Since 2013, we have helped hundreds of entrepreneurs turn an idea into a business, and we are very proud of their many achievements. Here are some of our Accelerate Cambridge ventures that have been most successful in securing funds from investors.

Venture Founded in Funds raised Employees Industry

bit.bio

bit.bio is a synthetic biology company providing human cells for research, drug discovery and cell therapy.

View venture
2016 £124m 101-250

Healthcare, pharma, biotech

Healx

Healx is a social enterprise passionate about finding new therapeutic solutions to cure patients with rare diseases.

View venture
2014 £66.4m 51-100

Healthcare, pharma, biotech

Speechmatics

Speechmatics provides cloud-based speech recognition services that convert speech-to-text.

View venture
2006 £60.1m 101-250

Technology

Nuclera

Nuclera is a US and UK-based biotechnology company driven by the mission to better human health by making proteins accessible.

View venture
2013 £52.3m 101-250

Healthcare, pharma, biotech

VocalIQ

VocalIQ was formed in March 2011 to exploit technology developed by the Spoken Dialogue Systems Group at University of Cambridge, UK.

View venture
2011 £49.5m 1-10

Computing, data, software

Cytora

Cytora is the configurable platform that enables commercial insurers to create digital workflows by digitising, evaluating and routing risks.

View venture
2014 £31.6m 11-50

Risk management

PostEra

PostEra is the first company to algorithmically complete the ‘design-make-test’ cycle of drug discovery.

View venture
2019 £20.8m 11-50

Healthcare, pharma, biotech

Better Origin

Better Origin sets out to transform food waste into sustainable products with the help of insects.

View venture
2015 £19.2m 11-50

ESG, climate action

Hummingbird Technologies

Hummingbird Technologies is an artificial intelligence SaaS platform that provides actionable intelligence to farmers and agri-businesses at key decision-making times in the growing season.

View venture
2015 £16.5m 11-50

Engineering

PharmEnable

PharmEnable explores new areas of chemical space that no one else is currently searching to enable the development of vital new medicines.

View venture
2016 £12.2m 1-10

Healthcare, pharma, biotech

Dogtooth Technologies

Dogtooth Technologies is a Cambridge-based technology start-up that sells smart robots for harvesting soft fruits such as strawberries and raspberries.

View venture
2014 £11.8m 11-50

Agritech

Sano Genetics

Sano’s patient finding and engagement services enable researchers to deliver precision medicine clinical trials at increased speed and lower cost.

View venture
2017 £11.8m 60

Healthcare, pharma, biotech

FA-Bio

FA-Bio provides game-changing bio-products for agriculture that can replace chemical inputs.

View venture
2015 £9.5m 1-10

Agriculture

Charco Neurotech

Charco Neurotech developed CUE1, a focused vibrotactile stimulation device for people with Parkinson’s.

View venture
2019 £8.7m 11-50

Healthcare, pharma, biotech

KisanHub-Arjun Technology Ventures

KisanHub Agri-Food Supply Chain software helps producer groups to transform their supply chain and improve margins with greater visibility and data driven insights.

View venture
2014 £7.3m 11-50

Agriculture

Cambridge Cancer Genomics

Cambridge Cancer Genomics developed precision oncology solutions to transform the way cancer patients are treated.

View venture
2016 £7.2m 11-50

Healthcare, pharma, biotech

MediaGamma/Nozzle ai

MediaGamma is transforming the way digital media is valued, traded, and measured.

View venture
2014 £5.8m 11-50

Arts, entertainment, media

Antiverse

Antiverse is developing a revolutionary technology to predict antibody drug hits in a single day rather than in months through the traditional methods.

View venture
2017 £5.3m 11-50

Pharmaceutical

Spotta

Spotta intends to be the world leader in smart pest detection.

View venture
2008 £5.1m 1-10

Agriculture

Prosoma

Prosoma is developing a comprehensive digital therapeutics programme, designed exclusively for cancer patients, including CBT, RBT, mindfulness, relaxation and breathing therapies.

View venture
2017 £4.7m 11-150

Healthcare, pharma, biotech

Polysolar

Polysolar produces window glass that generates electricity.

View venture
2007 £4.6m 1-10

Construction, engineering

Edozo

Edozo is an online community for commercial property professionals who wish to share high quality comparable evidence.

View venture
2016 £4.6m 11-50

Real estate

52North

52 North was launched to develop a transformative new medical device, NeutroCheck, presenting tangible efficiencies in patient care and healthcare resource, both financial and human.

View venture
2018 £4.3m 1-10

Healthcare, pharma, biotech

Satavia

Satavia is an analytics and visualisation company that develops bespoke environmental awareness solutions for all segments of the aviation market.

View venture
2013 £4.06m 11-50

Automotive, aerospace

Animal Alternative Technologies

Satavia is an analytics and visualisation company that develops bespoke environmental awareness solutions for all segments of the aviation market.

View venture
2020 £3.9m 1-10

Manufacturing

Spirea

Spirea is developing the next generation of antibody drug conjugate cancer therapeutics.

View venture
2017 £2.9m 1-10

Healthcare, pharma, biotech

Syrona Health

Syrona Health, a non-invasive, rapid diagnostic tool helps women better manage their own reproductive health.

View venture
2019 £2.6m 11-50

Healthcare, pharma, biotech

Kalium Health

Kalium Health is developing the world’s first blood potassium test suitable for home use.

View venture
2018 £2.5m 11-50

Healthcare, pharma, biotech

Qureight

Qureight combines technology and life sciences to generate new knowledge and transform the way we use clinical data.

View venture
2018 £2.5m 1-10

Healthcare, pharma, biotech

Upfront diagnostics LTD

Upfront Diagnostics has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion.

View venture
2017 £2.5m 1-10

Healthcare, pharma, biotech

Top